3-iodobenzylguanidine has been researched along with Dyslipidemias in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ascaso, JF; Carmena, R; Civera, M; Molina, M; Navarro, I; Real, JT | 1 |
1 review(s) available for 3-iodobenzylguanidine and Dyslipidemias
Article | Year |
---|---|
[Catecholamine-induced cardiomyopathy triggered by pheochromocytoma].
Topics: 3-Iodobenzylguanidine; Acute Coronary Syndrome; Adrenal Gland Neoplasms; Adrenalectomy; Catecholamines; Combined Modality Therapy; Diagnosis, Differential; Dyslipidemias; Female; Humans; Hypertension; Metanephrine; Middle Aged; Myocardial Infarction; Phenoxybenzamine; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Vanilmandelic Acid; Ventricular Dysfunction, Left | 2011 |